Form 4 for FRHC Freedom Holding Corp.
Accepted 2026-07-22 16:10:46 ET · period of report 2025-09-16 · accession 0000929638-26-002670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-22 16:10 | 2025-09-16+ | FRHC | CHERDABAYEV BORIS | Dir | A - Grant | $0.00 | +1,434 | 798 | New | $0 |
| M | 2026-07-22 16:10 | 2025-11-04+ | FRHC | CHERDABAYEV BORIS | Dir | S - Sale | $135.84 | -636 | 121 | -84% | -$86.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2025-09-16 | A | A | 757 | $0.00 | 757 | D | — | — | (F1) Mr. Cherdabayev was awarded 757 restricted shares of common stock of Freedom Holding Corp. (the "Company") on September 16, 2025, under the Company 2019 Equity Incentive Plan. Assuming satisfaction of applicable vesting conditions, which include continuous service with the Company and market price conditions tied to the performance of the Company's common shares, vesting of the shares occurred on September 16, 2025. |
| 2 | Common | Common | 2025-11-04 | S | D | 300 | $141.88 | 457 | D | — | — | (F3) Reflects the weighted average sale price on November 4, 2025. The shares were sold in multiple transactions at prices ranging from $141.81 to $141.92, inclusive. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| 3 | Common | Common | 2025-11-06 | S | D | 150 | $136.33 | 307 | D | — | — | (F4) Reflects the weighted average sale price on November 6, 2025. The shares were sold in multiple transactions at prices ranging from $136.24 to $136.37, inclusive. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| 4 | Common | Common | 2025-12-29 | S | D | 186 | $125.72 | 121 | D | — | — | (F5) Reflects the weighted average sale price on December 29, 2025. The shares were sold in multiple transactions at prices ranging from $125.70 to $125.79, inclusive. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| 5 | Common | Common | 2026-06-11 | A | A | 677 | $0.00 | 798 | D | — | — | (F2) Mr. Cherdabayev was granted 677 shares of restricted common stock of the Company on April 1, 2026, under the Company's 2019 Equity Incentive Plan, pursuant to a Restricted Stock Award Agreement executed on June 11, 2026. The shares became fully vested on June 11, 2026, the date the Restricted Stock Award Agreement was executed and the transaction became effective. |